Confined or spread disease-Spread into the peritoneum Posts on Medivizor
Navigation Menu

Confined or spread disease-Spread into the peritoneum Posts on Medivizor

Looking for patients with advanced colorectal cancer to test an experimental treatment

Posted by on Sep 10, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1/2 trial is examining the effectiveness of treatment with GB1275 alone or in combination with immunotherapy in patients with advanced solid tumors such as colorectal cancer. The main outcome to be measured will be dose toxicity and tumor response to the treatment. This study is being conducted in Tennessee and Texas, US. The...

Read More

Searching for patients with advanced colorectal cancer to test a new combination therapy

Posted by on Aug 22, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1b/2 trial will investigate the safety of cabozantinib (Cabometyx) with atezolizumab (Tecentriq) in patients with advanced solid tumors. The main outcomes will be the maximum tolerated dose (MTD) and overall response rate (ORR). The details Advanced cancers have limited treatment options. Surgery may not be possible. In many...

Read More

Looking for patients with advanced colorectal cancer to test a new drug

Posted by on Jun 28, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1 study will investigate the dose range and effectiveness of an experimental drug, XmAb23104, in the treatment of advanced colorectal cancer and other solid tumors.  The main outcome will be the safety and tolerability of XmAb23104. This trial is recruiting in Georgia, Texas, and Virginia, the United States. The details...

Read More

Looking patients with advanced cancer to test a new immunotherapy combination

Posted by on May 31, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 1/2 trial will investigate BMS-986253, an experimental drug, in combination with nivolumab (Opdivo) to treat advanced cancer. The main outcomes will be the occurrence of side effects and tumor response. The details Advanced cancers have limited treatment options. New drugs are in development to improve patient prognosis. These...

Read More

Looking for participants to test a new treatment combination for advanced colorectal cancer

Posted by on Apr 17, 2019 in Colorectal cancer | 0 comments

In a nutshell This trial is examining the effectiveness and safety of treatment with nivolumab (Opdivo) and relatlimab in patients with advanced colorectal cancer. The main outcome to be measured will be tumor response to the treatment. This trial is being conducted in Maryland, US. The details Colorectal cancer is the third most common cancer in the...

Read More

Can CEA levels predict tumor response to treatment in advanced colorectal cancer?

Posted by on Feb 12, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the relationship between changes in the levels of carcinoembryonic antigen (CEA) and colorectal cancer response to treatment. Researchers suggested that CEA levels are associated with tumor response and can be used as a prognostic factor. Some background In 2014 the European Society for Medical Oncology...

Read More

Looking for patients with advanced colorectal cancer to a test two different treatment combinations

Posted by on Jan 31, 2019 in Colorectal cancer | 0 comments

In a nutshell This phase 3 trial is examining the effectiveness of arfolitixorin versus leucovorin (folinic acid) when added to a combined treatment with 5-fluorouracil, oxaliplatin, and bevacizumab (FOB) to treat advanced colorectal cancer. The main outcome to be measured is the cancer response to the treatment. The details Treatment with...

Read More

Evaluating Cetuximab plus FOLFOX-4 chemotherapy for patients with metastatic colorectal cancer

Posted by on Oct 13, 2018 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of cetuximab (Erbitux) combined with FOLFOX-4 (leucovorin, fluorouracil, and oxaliplatin) chemotherapy to treat metastatic (spread to other parts of the body) colorectal cancer (mCRC). Researchers suggested that this treatment is associated with improved cancer outcomes. Some background...

Read More

HIPEC combined with surgery is effective in colorectal cancer with peritoneal metastasis

Posted by on Nov 7, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients with early stage peritoneal metastasis (PM; when the cancer spreads to the abdominal lining). Researchers suggested that HIPEC may benefit these patients. Some background The peritoneal region is the second...

Read More

Malnutrition caused by pre-surgery chemotherapy is associated with rectal cancer treatment outcomes

Posted by on Jun 3, 2016 in Colorectal cancer | 0 comments

In a nutshell This study investigated the association between malnutrition caused by pre-surgery chemotherapy and radiation (CRT) and rectal cancer treatment tolerance and anastomotic leakage (AL; leakage of intestinal fluids). Researchers reported that malnutrition related to CRT is associated with treatment tolerance and AL. Some background CRT...

Read More

Stricter adherence to chemotherapy drug dosage recommendations improve survival outcomes in stage 3 colon cancer patients

Posted by on Nov 6, 2015 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effect of chemotherapy drug dose on the survival outcomes of stage 3 colon cancer patients.  Some background Relative dose intensity (RDI) refers to the proportion of the standard drug dose received during chemotherapy. Previous studies have shown that an RDI greater than 70% is associated with better...

Read More